We are live on ! Find out more
BBH icon

VanEck Biotech ETF
BBH

102 hedge funds and large institutions have $129M invested in VanEck Biotech ETF in 2020 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 28 increasing their positions, 16 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

271% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 7

112% more call options, than puts

Call options by funds: $1.37M | Put options by funds: $646K

77% more capital invested

Capital invested by funds: $73M → $129M (+$56.4M)

75% more repeat investments, than reductions

Existing positions increased: 28 | Existing positions reduced: 16

23% more funds holding

Funds holding: 83 → 102 (+19)

4.58% more ownership

Funds ownership: 22.78% → 27.36% (+4.6%)

Holders
102
Holders Change
+19
Holders Change %
+22.89%
% of All Funds
2.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
26
Increased
28
Reduced
16
Closed
7
Calls
$1.37M
Puts
$646K
Net Calls
+$723K
Net Calls Change
+$1.31M

Top Buyers

Rank Fund Capital Flow
1
PAG
Pinnacle Advisory Group
Maryland
+$17.7M
2
Morgan Stanley
Morgan Stanley
New York
+$3.36M
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$2.25M
4
LPL Financial
LPL Financial
California
+$2.05M
5
BRC
BHF RG Capital
Arizona
+$1.67M

Top Sellers

Rank Fund Capital Flow
1
Bank of America
Bank of America
North Carolina
-$4.57M
2
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$440K
3
UBS Group
UBS Group
Switzerland
-$361K
4
SBH
Segall Bryant & Hamill
Illinois
-$251K
5
CG
Caprock Group
Idaho
-$209K
Name Holding Trade Value Shares
Change 		Change in
Stake
Ameriprise
26
Ameriprise
Minnesota
$984K +$617K +4,061 +205%
PSF
27
Pacific Sun Financial
California
$982K – – –
GJIC
28
Gamble Jones Investment Counsel
California
$978K – – –
ACA
29
Atlas Capital Advisors
Wyoming
$978K – – –
RJFSA
30
Raymond James Financial Services Advisors
Florida
$977K +$265K +1,745 +41%
Wells Fargo
31
Wells Fargo
California
$974K +$153K +1,007 +20%
PNC Financial Services Group
32
PNC Financial Services Group
Pennsylvania
$848K +$304 +2 +0%
AL
33
Aspiriant LLC
California
$762K -$93.5K -615 -12%
FNBOSM
34
First National Bank of South Miami
Florida
$651K -$27.4K -180 -4%
FAAS
35
First Allied Advisory Services
California
$614K +$573K +3,770 New
WS
36
Wedbush Securities
California
$612K +$571K +3,758 New
IAMOG
37
Investors Asset Management of Georgia
Georgia
$603K – – –
SC
38
Scotia Capital
Ontario, Canada
$589K -$7.6K -50 -1%
SBH
39
Segall Bryant & Hamill
Illinois
$585K -$251K -1,650 -31%
WJWM
40
Williams Jones Wealth Management
New York
$572K – – –
Truist Financial
41
Truist Financial
North Carolina
$558K – – –
Cambridge Investment Research Advisors
42
Cambridge Investment Research Advisors
Iowa
$508K +$236K +1,550 +99%
TC
43
Telemus Capital
Michigan
$495K -$15.2K -100 -3%
Bank of New York Mellon
44
Bank of New York Mellon
New York
$491K – – –
PAG
45
Private Advisor Group
New Jersey
$473K -$45.6K -300 -9%
WANY
46
Wealthspire Advisors (New York)
New York
$448K +$418K +2,752 New
PP
47
Prudential plc
United Kingdom
$407K +$380K +2,500 New
Osaic Holdings
48
Osaic Holdings
Arizona
$389K +$49.2K +324 +16%
MWA
49
MFA Wealth Advisors
Pennsylvania
$293K – – –
FFN
50
Focus Financial Network
Minnesota
$287K – – –
1
2
3 4 5

BBH Hedge Fund Activity: Q2 2020 in Review

102 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in VanEck Biotech ETF (BBH) for Q2 2020, worth a combined $129M — up 77% from $73M a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new BBH positions and 7 closed out — a net gain of 19 holders — while 28 added to existing stakes and 16 trimmed.

The largest buyer was Pinnacle Advisory Group, adding an estimated $17.7M. The largest seller was Bank of America, cutting an estimated $4.57M.

  • 102 institutional investors held VanEck Biotech ETF (BBH) as of Q2 2020, up from 83 in Q1 2020.
  • Funds reported $129M of VanEck Biotech ETF stock for Q2 2020, up 77% quarter-over-quarter.
  • 26 funds opened new VanEck Biotech ETF positions in Q2 2020 and 7 closed out, a net change of +19 holders.
  • The largest VanEck Biotech ETF buyer in Q2 2020 was Pinnacle Advisory Group, an estimated $17.7M added.
  • The largest VanEck Biotech ETF seller in Q2 2020 was Bank of America, an estimated $4.57M sold.

Based on aggregated 13F filings for Q2 2020.